secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2025-05-06T23:59:59+00:00
Accession:  0001641172-25-008750
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MAIA raises $1.08M in private placement; warrants corrected to 1-year lockout, 6-year term
--------------------------------------------------------------------------------

- 719,999 shares sold at $1.50/share; each with a warrant to buy one share at $2.05.
- Warrants exercisable starting 1 year from issuance, expiring 6 years from issuance date.
- Directors Stan Smith ($100K) and Ramiro Guerrero ($30K) participated in the offering.
- Net proceeds to fund Part C of THIO-101 Phase II trial and working capital.
- Closing expected on or about May 7, 2025, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000164117225008750/0001641172-25-008750-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000164117225008750/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-008750

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer